SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " novo " 208 found 🔀 AI-powered Shuffle
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
Thunder roll to dominant win over LeBron James, Lakers to grab 1-0 lead
The Thunder have now won six straight postseason games, matching a franchise record.
Thunder roll to dominant win over LeBron James, Lakers to grab early 1-0 lead
The Thunder have now won six straight postseason games, matching a franchise record.
Lenovo Legion Tab (Gen 5) launches in the US with 8.8-inch display, $849 worth of RAM
Lenovo has just opened up sales of its new Legion Tab (Gen 5) in the US, with the compact Android...
Lenovo's New ThinkPad Headset Uses Ceva Spatial Audio to Make Entertainment Content More Immersive and Drive All-Day Use
/PRNewswire/ -- As hybrid work continues to blur the line between productivity and entertainment, Lenovo is betting that better audio, not just better video,...
Carolina Holds Off Philadelphia – Hurricanes 3, Flyers 2 OT
The Carolina Hurricanes fell behind for the first time this postseason but regrouped and went on to defeat the Philadelphia Flyers 3-2, in overtime on Monday night at the Lenovo Center. The win gives the Hurricanes a 2-0 lead over the Flyers in their Round 2 matchup. They are 6-0 so far this postseason. Taylor […]
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
Apotex Gets Health Canada Approval for Generic Semaglutide
Apotex receives Health Canada approval for generic semaglutide injection, matching all commercial formats of Novo Nordisk's Ozempic for type 2 diabetes treatmen
Health Canada approves first generic version of Novo Nordisk's Ozempic
Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic made by Indian drugmaker Dr Reddy's Laboratories , its website showed on Tuesday.
Lenovo acquires Phoenix Technologies’ BIOS business
Lenovo buys Phoenix Technologies' firmware business I guess we all saw “Phoenix BIOS” at some point in our engagement with PCs. You should probably know
Hurricanes 3, Senators 2
Jordan Martinook notched the game-winner in double overtime to lead the Carolina Hurricanes to a 3-2 victory over the Ottawa Senators on Monday night at the Lenovo Center. The win gives Carolina a 2-0 lead in this playoff series and allows them to keep their home ice advantage. The Canes thought they had won the […]
Novo Nordisk CEO: This is where science meets speed and scale
Maziar Mike Doustdar, CEO of Novo Nordisk, says AI partnership with OpenAI will speed drug discovery and delivery, boost accuracy and strengthen confidence in Wegovy despite rising competition.
Best 2-in-1 Laptops (2026): Microsoft, Lenovo, and the iPad
Whether you want a detachable tablet or a laptop screen that spins, these 2-in-1 devices manage to balance being both a tablet and a laptop.
Sports Playbook for Business: Leading with Speed, Clarity, and Purpose
Novo Nordisks Aleksandar Ciric writes that leaders can apply sports principles such as speed of action, clarity, and responsiveness to be successful in life sciences.
I tested three Windows laptops in the MacBook Neo’s price range — there’s no contest
It’s a bloodbath.
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations.
Dangerous "NoVoice" malware found in over 50 Play Store apps that were installed 2.3 million times
Luckily, if you have an Android device that was updated after a certain date, you're okay.
Metro Division Champions – Hurricanes 4, Islanders 3
Seth Jarvis scored two goals and had an assist as the Carolina Hurricanes dominated the New York Islanders, 4-3 on Saturday night at the Lenovo Center. While the score was close, the Canes controlled puck possession and shots. The home team outshot the visitors 13-4 in the first period and 18-2 in the second. Overall, […]
Lenovo Legion Go 2 suddenly costs $650 more as RAMageddon lays waste to gaming hardware
$2,000 for a Z2 Extreme.
Legion Go 2 now costs $2000, twice as much as ROG Xbox Ally X
Best Buy now lists Lenovo Legion Go 2 at 48% above launch price Lenovo launched the Legion Go 2 in the US at $1,349.99 for the Ryzen Z2 Extreme, 32GB, 1TB
Lenovo has raised prices on its Android tablets, ended Legion Tab sales
Lenovo has ended sales of its Legion Tab (Gen 3) ahead of an upgrade and, in turn, more expensive sequel,...
You're Running Out Of Time For Laptop and Desktop Deals at Amazon's Big Spring Sale
Amazon's massive sale ends at midnight tomorrow, so if you're on the market for a laptop or desktop, grab one from Apple, Samsung, Lenovo, and other top brands before they're gone.
Health Care Roundup: Market Talk
Find insight on Novo Nordisk, Novartis, Top Glove and more in the latest Market Talks covering Health Care.
Ozempic Is About to Go Generic in India, China and Canada
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Intel reportedly limits first Core 200HX Plus shipments to select laptop makers
Core Ultra 200HX Plus gaming laptops arrive first on Lenovo Legion and Razer Blade systems Intel’s new Core Ultra 200HX Plus laptop processors are not
Ozempic Linked to Lower Risk of Plunging Mental Health in Study
Swedish people with depression and anxiety who took Novo Nordisk A/S’s blockbuster shots Ozempic and Wegovy were less likely to see their mental health get worse, the latest data to suggest that popular diabetes and obesity drugs could also have a broader impact on well-being.
Lenovo brings retro arcade cabinet gaming to high-end Android tablets with new releases
Lenovo has released a new set of accessories for its compact gaming tablets. Compatible with multiple tablet generations, the Legion Y700 Arcade Dock comes in three finishes with dedicated SNK versions too.
Why quitting Ozempic and GLP-1s can be bad for your heart health
People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.
Lenovo Partners with Eva Longoria to Launch Global Search for Business “Twins”
Lenovo's official site for press materials and original stories about the vision and passion behind the technology.
Lenovo Unveils Next-Gen Workstations and Announces the World's First 1,000 Wh/L Silicon-Anode Battery for Notebooks and Workstations
Lenovo introduces the next-generation of AI workstations optimized for on-device AI development, inference and creation, including the ThinkPad P14s i Gen 7, ThinkPad P14s Gen 7 AMD, ThinkPad P16s i Gen 5, ThinkPad P16s Gen 5 AMD, ThinkPad P1 Gen 9 and the powerhouse desktop ThinkStation P5 Gen 2. ...
Going Panther Lake very quickly: Lenovo updates ThinkPad P1 line with the P1 Gen 9 after just six months
An unexpected update: Lenovo is already replacing the ThinkPad P1 Gen 8 with the next gen model, the new ThinkPad P1 Gen 9. This new version is only a small update, focused mainly on internal changes.
What are peptides, and are they safe? Here's what to know
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.
Penguins make unbelievable comeback but lose shootout
Noel Acciari and Bryan Rust scored late goals as the resilient but depleted Pittsburgh Penguins (32-17-14) mounted a miraculous comeback to force overtime against the Carolina Hurricanes at the Lenovo Center.
Asset Manager Exits Shares of Hims & Hers Health
Hims & Hers Health has struggled, but it just inked a new partnership with Novo Nordisk.
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal
On March 9, 2026, a new Novo Nordisk pact reshaped this telehealth player’s GLP-1 strategy, margins, and legal risk profile.
Health Care Roundup: Market Talk
Find insights on Roche’s breast-cancer drug, the partnership between Hims & Hers and Novo Nordisk and more in the latest Market Talks from the health-care sector.
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Hims & Hers Health has agreed to stop selling compound versions of Novo Nordisk's Wegovy and other weight-loss drugs, ending a patent lawsuit for now.
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight los…
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss medicines sold through the Hims platform.
Hims & Hers Health and Novo Nordisk End Lawsuit Over Weight Loss Medications, Enter Collaboration
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss medicines sold through the Hims platform. Shares of Hims & Hers Health Inc. jumped more than 40% in ...
Hims & Hers Announces Strategic Shift for US Weight Loss Business
Starting with a new collaboration with Novo Nordisk, the company announced plans to align its US and global strategies with a focus on an increasing variety of FDA-approved GLP-1s Hims Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match the company’s approach globally. In the US, the company now plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medications and offer compounded semaglutide through the platform on a limited scale. By aligning its domestic and international models in weight loss, Hims Hers will become the largest global consumer health platform for access to more affordable, approved medications. The US weight loss landscape has transformed dramatically since Hims Hers entered the market in 2023. Progress in the industry has made a broader range of FDA-approved GLP-1 treatments
Using Lenovo's Yoga Book 3D Laptop Felt Like Borrowing Tools From the Future
Used to making fists at your laptop screen? You'll love this. The Yoga Book Pro 3D Concept blends glasses-free 3D visuals, gesture controls, and dual touch screens to reimagine how creators work with digital objects. I gave it a test-drive.
Lenovo Unveils an Attachable AI Agent 'Companion' for Their Laptops
As the Mobile World Conference begins in Spain, Lenovo brought a new attachable accessory for their laptops — an AI agent. CNET reports: The little circular module perches on the top of your Lenovo laptop display, attached via the magnetic Magic Bay on the rear. The module is home to an adora...
Lenovo shows off snap-together laptop with removable keyboard, screen, and ports
: New ThinkPads also come in blue, get perfect fixability score
A robot arm with puppy dog eyes is just one of Lenovo’s new desktop AI concepts
Lenovo’s latest concept devices use AI to streamline your work day.
Lenovo’s Latest Wacky Concepts Include a Laptop With a Built-in Portable Monitor
At MWC 2026, the company also showed off a dual-screen Yoga Book with 3D capabilities, and the Legion Go Fold—a gaming handheld with a folding screen that converts into a mini laptop.
Lenovo Teases Modular Laptop, Foldable Gaming Handheld Concepts
Lenovo Group Ltd. revealed several new proof-of-concept prototypes, including a “modular” laptop with two displays and detachable ports, along with a portable gaming device featuring a folding display.
Lenovo ThinkBook Modular AI PC and Yoga Book Pro 3D leak ahead of MWC 2026
Lenovo experimenting with concept PCs focusing on modular and dual-display designs Lenovo is expected to show multiple concept PCs at MWC 2026 in
Novo Nordisk to halve US list price of Wegovy from 2027
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year to $675 a month, the Danish
Lenovo leak reveals a foldable gaming handheld that’s also a Windows laptop
The transformer of gaming handhelds.
Lenovo Legion Go Fold concept leaks with 7.7-inch to 11.6-inch folding POLED display, Lunar Lake SoC
Legion Go Fold concept to be presented next month We have just received a tip from Windows Latest that they have just shared the first pictures of
Eli Lilly's orforglipron beats Novo Nordisk's GLP-1 pill in tests
Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
This Looming Drug Development Gap Could Impact Patients' Health
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss
The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lilly’s Zepbound.
Nvidia re-enters PC market with AI-powered laptop chips
Nvidia plans an AI laptop chip comeback with Dell/Lenovo, partnering with MediaTek and Intel to power next-gen Windows PCs—see what it means for NVDA.
AMD Seemingly Stops Driver Updates for Ryzen Z1 Extreme Processor
AMD has reportedly stopped driver updates for its Ryzen Z1 Extreme APU solution for handheld consoles, according to the latest Lenovo Korea update. This means that only after 2 and a half years, AMD is pulling support for its SoC, leaving many enthusiasts in a difficult spot. Confirmation from multi...
Lenovo reportedly ends driver updates for Legion Go based on Ryzen Z1 Extreme
Lenovo Korea support reply suggests no more Legion Go driver updates, warns against using Legion Go S BIOS and drivers A Lenovo Korea support response
Cellular mechanisms of brain lipid metabolism in health and disease
Nature Cell Biology - This Review discusses brain lipid metabolism from a cellular perspective, focusing on lipid uptake, de novo synthesis, storage, breakdown and intercellular transfer, and...
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows
Hedge fund bets against Hims & Hers Health hit their highest in at least a year in January, just before the online telehealth firm clashed with Novo Nordisk over its cut-price weight-loss pill, according to data shared with Reuters by Hazeltree.
Health Care Roundup: Market Talk
Find insight on Novo Nordisk, Moderna, EssilorLuxottica and more in the latest Market Talks covering Health Care.
10 Triangle businesses get big surprise from Lenovo, Carolina Hurricanes
RALEIGH, N.C. (WNCN) — The Carolina Hurricanes and Lenovo are helping to boost small businesses across central North Carolina. Ten businesses were surprised with $5,000 worth of Lenovo technology …
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and more
These are the stocks posting the largest moves in premarket trading.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Hims & Hers will stop selling compounded version of Novo’s obesity pill
Hims & Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.
VIEW Hims and Hers Health's compounded Wegovy pill offering fuels market jitters
Hims & Hers said it would begin offering compounded versions of Novo Nordisk's Wegovy pill at an introductory price of $49 per month.
Exclusive: Hims and Hers Health launches copy of Wegovy pill at $49
Online telehealth company Hims and Hers Health will begin offering copies of Novo Nordisk's new Wegovy pill at an introductory price of $49 per month, the company said Thursday, about $100 less than the brand name.
Bussi Does it Again – Hurricanes 4, Senators 3
The Carolina Hurricanes won a tight battle with the Ottawa Senators, 4-3 on Tuesday night at the Lenovo Center. Goaltender, Brandon Bussi earned the win and continued with his magical season by improving his overall record this season to 22-3-1. While Bussi allowed three goals on the 25 shots he faced, many of his saves […]
The Big ChromeOS and Android Merger May Be Google’s Last Walled Garden
The Google-pilled ChromeOS may die so that ‘Aluminum’ will live.
Google court filings suggest Google's ChromeOS has an expiration date
ChromeOS may be canned once the current support guarantee has run its course.
Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business
Danish drug maker Novo Nordisk said on Wednesday it had appointed Jamey Millar head of its U.S. business, and Hong Chow head of product and portfolio strategy.
Legion Y700: Lenovo officially confirms next-gen compact Android gaming tablet
Lenovo has officially confirmed the next-generation Legion Y700, with promotional images showing the tablet's rear design in two color options and an RGB ring light. A leak has separately revealed the device's key specifications and launch month.
Lenovo Legion gaming laptop with AMD Strix Halo shows up alongside NVIDIA N1X update
Lenovo Legion 7 15ASH11 is likely powered by AMD Strix Halo List of gaming laptops using only AMD Ryzen AI MAX 300 is growing. Lenovo’s Legion Space
Lenovo’s 13-inch ‘Sapphire’ Chromebook tablet just checked another box on my high-end wish list
As we approach the actual release of ‘Sapphire’ - the highly anticipated, Lenovo-built Chromebook tablet with some decidedly Google-y features - this device just keeps getting better. Over the past...
Sony Unveils $230 Clip-On Earbuds, Joining a Growing Wave
Sony Group Corp. introduced its latest pair of consumer earbuds, with a clip-on design that resembles recent efforts from Bose Corp., Lenovo Group Ltd.’s Motorola unit and Huawei Technologies Co.
UK health regulator approves up to 7.2 mg weekly dose of Wegovy for obesity patients
Britain's health regulator approved a maximum dose of up to 7.2 miligrams per week of Novo Nordisk's blockbuster weight-loss drug Wegovy for patients with obesity only, it said on Friday.
The 4 Coolest Tech Innovations From CES 2026 You Need To Check Out
Among the new technologies at CES 2026, the TCL SQD-Mini LED TV, Lenovo Legion Pro Rollable laptop, Jackery Solar Mars Bot, and Nvidia DLSS 4.5 stand out.
Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill
In recent days, Amazon Pharmacy announced it would begin offering Novo Nordisk’s Wegovy once-daily weight-loss pill through both insurance and cash-pay channels, including future availability via its pharmacy kiosks. This move directly targets the fast-growing weight management segment where Hims & Hers Health participates, raising fresh questions about how differentiated and resilient its broader telehealth platform and recurring-care model really are beyond GLP-1 offerings. We’ll now...
AMD shows first renders of Ryzen AI 400 for AM5 socket
AMD Ryzen AI PRO 400 for AM5 socket During Lenovo’s CES 2026 keynote, a slide briefly showed Ryzen AI PRO 400 on an AM5 socket. That is the clearest
Three in a Row – Hurricanes 5, Ducks 2
After a slow first period, the Carolina Hurricanes sharpened up their game and went on the defeat the Anaheim Ducks, 5-2 on Thursday night at the Lenovo Center. It was the third straight win for Carolina while the Ducks have now lost eight in a row. The home team got off to a bit of […]
The coolest laptops we saw at CES 2026
New chips, new form factors, and some new concepts.
Lenovo CEO addresses AI skeptics at CES: 'Nobody can avoid it.'
Mashable spoke to Yang following Lenovo's keynote CES event at The Sphere.
Lenovo is building an AI assistant that ‘can act on your behalf’
Qira, Lenovo’s biggest AI push yet, is designed to live across Lenovo laptops and Motorola phones.
Lenovo, Nvidia unveil AI cloud gigafactory
Lenovo unveiled an artificial intelligence cloud gigafactory with NVIDIA at the Consumer Electronics Show in Las Vegas on Tuesday, while also showcasing a slew of other products, including a new AI platform.
Global Blog | Motorola at Lenovo Tech World 2026
Motorola took the Lenovo Tech World 2026 stage in Las Vegas to unveil the most exciting tech yet, including a new form factor and franchise.
Lenovo Reimagines the Device Experience in the AI Era with Visionary Proofs of Concept at CES 2026
Lenovo is showcasing a series of proofs-of-concept that demonstrate bold new designs and an ecosystem of AI-enabled devices
Motorola Debuts Its First Book-Style Foldable and Wearable AI Concept
Lenovo Group Ltd.‘s Motorola unveiled its first folding phone that opens like a book or passport, a departure from the string of clamshell-style foldables that the brand has released over the last several years.
Lenovo's 14th-gen ThinkPad X1 Carbon comes with a new Space Frame design
The ThinkPad X1 Carbon Gen 14 Aura Edition and ThinkPad X1 2-in-1 Gen 11 Aura Edition come with a new design Lenovo has dubbed “Space Frame.”
Lenovo’s new All-in-One PC can sync its lighting to your notifications
A flashy new design
The new Lenovo Yoga Pro 9i laptop has a super-bright tandem OLED and magnetic stylus
Accompanying it is the Yoga Slim 7i Ultra, Lenovo’s slimmest and lightest Yoga.
Lenovo Debuts Space Frame Design in Latest ThinkPads at CES 2026
The new flagship X1 Carbon Gen 14 and companion X1 2-in-1 Gen 11 get new modular chassis for greater serviceability and longer lifespans.
You Love Your Ultrawide Gaming Monitor. What About an Ultrawide Gaming Laptop?
Lenovo brought a Legion gaming laptop to CES this year with a rollable OLED display that expands horizontally by six inches.
Lenovo’s Auto Twist laptop is going from concept to real product
The auto-opening ThinkBook Plus Gen 7 Auto Twist is actually coming out.
This ThinkPad laptop concept has a rollable display that wraps around its lid
And that lid is partially seethrough.
Lenovo’s second SteamOS handheld is the Legion Go 2
Lenovo continues its Valve experiment.
Lenovo’s new concept rollable could be the ideal gaming laptop
Gamers may have a new grail laptop.
Intel's Core Ultra Series 3 let me play 'Battlefield 6' at 190 fps on a Lenovo ultraportable
Intel's Arc graphics has come far enough to let me playing Battlefield 6 at insanely high fps rates.
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient
The medicine developed by the100-year old Danish drugmaker may impact patients' brains in surprising ways